145 related articles for article (PubMed ID: 33345424)
1. Trimester-specific reference intervals of TAT, TM, tPAI-C and PIC for healthy Chinese pregnant women.
Wu Y; Qiao Y; Zhang Y; Li Q; Zhang W
J Obstet Gynaecol Res; 2021 Jan; 47(1):368-374. PubMed ID: 33345424
[TBL] [Abstract][Full Text] [Related]
2. Changes of new coagulation markers in healthy pregnant women and establishment of reference intervals in Changsha.
Yang Y; Hu Y; Wu M; Xiang Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2022 Apr; 47(4):469-478. PubMed ID: 35545342
[TBL] [Abstract][Full Text] [Related]
3. Trimester-specific reference intervals of hemostasis biomarkers for healthy pregnancy.
Xiao H; Yu W; Li L; Yin X; Zhai Q; Hu D; Zhang X; Wang F
Scand J Clin Lab Invest; 2023 Oct; 83(6):379-383. PubMed ID: 37491076
[TBL] [Abstract][Full Text] [Related]
4. Performance evaluation of thrombomodulin, thrombin-antithrombin complex, plasmin-α2-antiplasmin complex, and t-PA: PAI-1 complex.
Chen Q; Shou W; Wu W; Wang G; Cui W
J Clin Lab Anal; 2019 Jul; 33(6):e22913. PubMed ID: 31090232
[TBL] [Abstract][Full Text] [Related]
5. Coagulation and Fibrinolysis Biomarkers as Potential Indicators for the Diagnosis and Classification of Ovarian Hyperstimulation Syndrome.
Li S; Qian Y; Pei Y; Wu K; Lu S
Front Med (Lausanne); 2021; 8():720342. PubMed ID: 34513881
[No Abstract] [Full Text] [Related]
6. Diagnostic and Prognostic Value of TAT, PIC, TM, and t-PAIC in Malignant Tumor Patients With Venous Thrombosis.
Zhou K; Zhang J; Zheng ZR; Zhou YZ; Zhou X; Wang LD; Suo B; Jiang XF; Liu PJ; Wang DH
Clin Appl Thromb Hemost; 2020; 26():1076029620971041. PubMed ID: 33141604
[TBL] [Abstract][Full Text] [Related]
7. The clinical significance of TAT, PIC, TM, and t-PAIC in vascular events of BCR/ABL-negative myeloproliferative neoplasms.
Huang K; Mo Q; Liao C; Feng S; Liu G; Jiang D; Lei P
Clin Exp Med; 2024 May; 24(1):107. PubMed ID: 38776019
[TBL] [Abstract][Full Text] [Related]
8. Studies on blood coagulation-fibrinolysis system regarding kallikrein-kinin system in the utero-placental circulation during normal pregnancy, labor and puerperium.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():320-9. PubMed ID: 1462839
[TBL] [Abstract][Full Text] [Related]
9. Evaluation the combined diagnostic value of TAT, PIC, tPAIC, and sTM in disseminated intravascular coagulation: A multi-center prospective observational study.
Mei H; Jiang Y; Luo L; Huang R; Su L; Hou M; Wang X; Deng J; Hu Y
Thromb Res; 2019 Jan; 173():20-26. PubMed ID: 30458338
[TBL] [Abstract][Full Text] [Related]
10. Performance evaluation of thrombus molecular markers thrombomodulin, thrombin-antithrombin complex, plasmin-α2-plasmin inhibitor complex, and tissue plasminogen activator-inhibitor complex by a chemiluminescence analyzer.
Lirong T; Minmin X; Manqiu Y; Yanping L
Hippokratia; 2022; 26(2):78-82. PubMed ID: 37188051
[TBL] [Abstract][Full Text] [Related]
11. Thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasmin-α2-plasmininhibitor complex (PIC), and tissue plasminogen activator-inhibitor complex (t-PAIC) assessment of fibrinolytic activity in postpartum hemorrhage: a retrospective comparative cohort study.
Wang L; Zhong J; Xiao D; Huang W; Zheng Z; Jiang Y
Ann Transl Med; 2022 Dec; 10(23):1273. PubMed ID: 36618792
[TBL] [Abstract][Full Text] [Related]
12. Clinical Efficacy of Soluble Thrombomodulin, Tissue Plasminogen Activator Inhibitor complex, Thrombin-Antithrombin complex,α2-Plasmininhibitor-Plasmin complex in Pediatric Sepsis.
Li J; Zhou J; Ren H; Teng T; Li B; Wang Y; Xiang L
Clin Appl Thromb Hemost; 2022; 28():10760296221102929. PubMed ID: 35603624
[TBL] [Abstract][Full Text] [Related]
13. Development of a chemiluminescence assay for tissue plasminogen activator inhibitor complex and its applicability to gastric cancer.
Ji Y; Qin Y; Tan Q; Qiu Y; Han S; Qi X
BMC Biotechnol; 2024 May; 24(1):30. PubMed ID: 38720310
[TBL] [Abstract][Full Text] [Related]
14. [Recent advances in the application of TAT, TM, t-PAIC and PIC in thromboembolism].
Li YJ; Zhang Q; Wang HC
Zhonghua Yu Fang Yi Xue Za Zhi; 2023 Oct; 57(10):1693-1703. PubMed ID: 37859391
[TBL] [Abstract][Full Text] [Related]
15. Circulating thrombomodulin and hematological alterations in type 2 diabetic patients with retinopathy.
Fujiwara Y; Tagami S; Kawakami Y
J Atheroscler Thromb; 1998; 5(1):21-8. PubMed ID: 10077454
[TBL] [Abstract][Full Text] [Related]
16. [Evaluation of Analytical Performance of HISCL TM, a Chemiluminescent Enzyme Immunoassay and the Use of Thrombomodulin as a Marker for Endothelial Dysfunction].
Nakanishi K; Masuda K; Mori N; Ishida A; Shiga S; Ichiyama S
Rinsho Byori; 2014 Oct; 62(10):942-7. PubMed ID: 27526539
[TBL] [Abstract][Full Text] [Related]
17. Value of TAT and PIC with D-dimer for cancer patients with metastasis.
Cui C; Gao J; Li J; Yu M; Zhang H; Cui W
Int J Lab Hematol; 2020 Aug; 42(4):387-393. PubMed ID: 32250048
[TBL] [Abstract][Full Text] [Related]
18. Studies of blood coagulation-fibrinolysis regarding kallikrein-kinin system in severe preeclampsia.
Mutoh S; Kobayashi M; Hirata J; Itoh N; Maki M; Komatsu Y; Yoshida A; Sasa H; Kuroda K; Kikuchi Y
Agents Actions Suppl; 1992; 38 ( Pt 2)():342-9. PubMed ID: 1462840
[TBL] [Abstract][Full Text] [Related]
19. A performance evaluation of chemiluminescence enzyme immunoassays on the Sysmex CN-6500 haemostasis analyser.
Gardiner C; Lane P; Tailor H; Machin SJ; Mackie IJ
Int J Lab Hematol; 2021 Dec; 43(6):1593-1598. PubMed ID: 34252265
[TBL] [Abstract][Full Text] [Related]
20. Clinical study on the feasibility of new thrombus markers in predicting massive cerebral infarction.
Zhao X; Yang S; Lei R; Duan Q; Li J; Meng J; Sun L
Front Neurol; 2022; 13():942887. PubMed ID: 36761916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
